News & Events
    • Arab Health 2016
    • 25TH~28TH January 2016Dubai International Convention & Exhibition Center, UAE
    • Merger Announcement
    • On January 1st, NanoEnTek merged with Bio Focus and inaugurated as a new integrated NanoEnTek.   From 1999 up to now, Bio Focus is an in-vitro diagnostic(IVD) company that lead diagnostic business for 16 years. Bio Focus has technical skills that can develop and manufacture internally core bio materials like monoclonal antibody, gold conjugate and so on. Now, about 30 kinds of rapid kits are producing and selling in world wide.   In 2000, NanoEnTek was established as an academy startup company in Seoul National University. NanoEnTek is a convergence company of IT·NT·BT that presents the world No.1 laboratory instrument by Lab-On-a-Chip platform technology based on medical engineering, mechanical engineering and biotechnology. We are a small giant of technology that earned about 10 million dollars by selling off only 2 patents among 100 patents.   These two companies based on different technology become one and maximize R&D synergy and reinforce products through technology convergence of nano-platform and bioreagent/material. NanoEnTek starts hopeful beginning to 'Global Top Digital POCT Creator' vision for 2020.   Among fast changes in healthcare environment, integrated NanoEnTek will prepare future for next new paradigm based on experience and strength that overcome a lot of challenges and difficulties. All of your interest and support would mean a lot to our growth and development. We ask for your encourage and continued support to us. 
    • 합병 안내문
    • 2016년 1월 1일, 나노엔텍과 바이오포커스가 합병하여 통합된 나노엔텍으로 새롭게 출범합니다.    바이오포커스는 1999년부터 현재까지 16년간 진단사업을 영위해온 체외진단(IVD) 전문 기업이며, 단일클론항체와 골드 콘쥬게이트 등 핵심 바이오원료를 자체적으로 개발, 제조하는 기술력을 보유하여 현재 30여종의 Rapid Kit를 생산 및 글로벌 판매하고 있습니다.   나노엔텍은 2000년 서울대 학내벤처로 시작해 의공학과 기계 〮생명공학을 근간으로 한 Lab-On-a-Chip플랫폼 기술로 세계 No.1의 실험기기를 선보인바 있는 IT〮NT〮BT 융합 기업입니다. 또한 100여건의 특허 중 2건의 매각만으로 한화 약 200억원을 벌어들인 기술강소기업 입니다.   서로 다른 뿌리의 기술을 가진 두 회사가 하나가 되어, 나노플랫폼과  바이오시약/원료 기술의 융합을 통해 R&D 시너지를 극대화하고 제품력을 강화하여, 2020년 'Global Top Digital POCT Creator'의 비전을 향한 희망찬 도약을 시작합니다.   헬스케어 환경이 빠르게 변화하는 가운데 통합 나노엔텍은 수많은 도전과 난관을 극복해온 경험과 저력을 바탕으로 다가올 새로운 패러다임의 미래를 준비할 것입니다. 우리의 성장과 발전에는 여러분의 따뜻한 관심과 성원이 가장 큰 힘이 됩니다. 앞으로도 변함없는 사랑과 격려를 부탁드립니다.      
    • 2015 MEDICA
    • November 16 ~ 19, 2015 Düsseldorf, Germany
  • NanoEnTek shifts the health-care paradigm to meet the needs of users by providing a personalized customer oriented technology. NanoEnTek, devoted to R&D for the last 13 years, developed state of the art technology utilizing chip technology and rapid diagnostic instrument FREND System. The FREND System is a revolutionary, ... smart, and easy-to-use immunoassay analyzer which provides users
  • The core technologies of NanoEnTek Inc. are based on Lab-on-a-chip technology related to microfluidics and microelectromechanical systems (MEMS) breaking through the limitations of con-ventional diagnostics of cen-tralized laboratories. Currently, the centralized laboratory testing accompanied with expensive and large-sized ... diagnostic equipments has been well established